Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of LSD and Psilocybin Effects
NCT03604744Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Mar 2019
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lysergide and psilocybin in mental disorder (5 arms), sponsored by University Hospital Basel. Primary endpoint: Altered States of Consciousness at 18 Months. Started Mar 2019; status: completed.
02
Drugs
Lysergidepsilocybin
03
Conditions
mental disorder
Beyond the preview
Go deeper on NCT03604744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604744.